Maintenance Capecitabine Extends Progression-Free Survival in Patients With Advanced Oesophagogastric Cancer Edited by Vineeta Teotia Medscape UK May 04, 2026

https://www.medscape.com/viewarticle/maintenance-capecitabine-extends-progression-free-survival-2026a1000dvi In a phase 2 trial, maintenance therapy with capecitabine significantly increased progression-free survival (PFS) compared with active surveillance in patients with advanced oesophagogastric adenocarcinoma (OGA) who achieved disease control after first-line chemotherapy.